Temasek Holdings’s BioNTech BNTX Stock Holding History

Temasek Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$134M	Hold	1,506,027	–	–	0.44%	44
2025 Q4	$143M	Hold	1,506,027	–	–	0.45%	41
2025 Q3	$149M	Hold	1,506,027	–	–	0.51%	35
2025 Q2	$160M	Sell	1,506,027 -301,205	-17%	-$30.4M	0.61%	26
2025 Q1	$165M	Hold	1,807,232	–	–	0.66%	30
2024 Q4	$206M	Hold	1,807,232	–	–	0.81%	23
2024 Q3	$215M	Hold	1,807,232	–	–	0.87%	24
2024 Q2	$145M	Sell	1,807,232 -1,623,018	-47%	-$148M	0.67%	28
2024 Q1	$316M	Sell	3,430,250 -1,087,830	-24%	-$104M	1.75%	17
2023 Q4	$477M	Hold	4,518,080	–	–	2.67%	13
2023 Q3	$491M	Hold	4,518,080	–	–	2.92%	11
2023 Q2	$488M	Buy	4,518,080 +140,058	+3%	+$15.8M	2.82%	12
2023 Q1	$545M	Hold	4,378,022	–	–	3.24%	10
2022 Q4	$658M	Hold	4,378,022	–	–	3.84%	7
2022 Q3	$591M	Buy	4,378,022 +3,840,388	+714%	+$587M	3.53%	7
2022 Q2	$80.2M	Hold	537,634	–	–	0.44%	36
2022 Q1	$91.7M	Hold	537,634	–	–	0.39%	43
2021 Q4	$139M	Hold	537,634	–	–	0.5%	40
2021 Q3	$147M	Hold	537,634	–	–	0.51%	41
2021 Q2	$120M	Hold	537,634	–	–	0.4%	38
2021 Q1	$58.7M	Hold	537,634	–	–	0.23%	45
2020 Q4	$43.8M	Hold	537,634	–	–	0.19%	45
2020 Q3	$37.2M	Buy	+537,634	New	+$38.6M	0.19%	42

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GSK plc London $599M AUM

Temasek Holdings's BNTX Position: Q1 2026 in Review

Temasek Holdings held its BioNTech (BNTX) position steady in Q1 2026 at 1,506,027 shares worth $134M. The position accounts for 0.44% of the portfolio, ranked #44.

Temasek Holdings first reported a position in BNTX in Q3 2020 and has held it in 23 quarters since. The position peaked at $658M in Q4 2022. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Temasek Holdings held 1,506,027 shares of BioNTech worth $134M as of Q1 2026.
Temasek Holdings left its BioNTech share count unchanged in Q1 2026.
BioNTech made up 0.44% of Temasek Holdings's portfolio in Q1 2026, its #44 holding.
Temasek Holdings first reported a position in BioNTech in Q3 2020 and has held it in 23 quarters since.
Temasek Holdings's BioNTech position peaked at $658M in Q4 2022.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Temasek Holdings's 13F filing for Q1 2026, filed 12 May 2026.